ALX Oncology Holdings Inc (ALXO)
1.29
+0.08
(+6.61%)
USD |
NASDAQ |
Nov 21, 16:00
1.29
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings Price to Book Value: 0.4973 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 0.4665 |
| November 19, 2024 | 0.4742 |
| November 18, 2024 | 0.4703 |
| November 15, 2024 | 0.4973 |
| November 14, 2024 | 0.5128 |
| November 13, 2024 | 0.5166 |
| November 12, 2024 | 0.5166 |
| November 11, 2024 | 0.5706 |
| November 08, 2024 | 0.559 |
| November 07, 2024 | 0.5821 |
| November 06, 2024 | 0.5899 |
| November 05, 2024 | 0.586 |
| November 04, 2024 | 0.5744 |
| November 01, 2024 | 0.559 |
| October 31, 2024 | 0.5513 |
| October 30, 2024 | 0.532 |
| October 29, 2024 | 0.5397 |
| October 28, 2024 | 0.5629 |
| October 25, 2024 | 0.5667 |
| October 24, 2024 | 0.5609 |
| October 23, 2024 | 0.64 |
| October 22, 2024 | 0.5783 |
| October 21, 2024 | 0.5783 |
| October 18, 2024 | 0.5706 |
| October 17, 2024 | 0.5821 |
| Date | Value |
|---|---|
| October 16, 2024 | 0.6014 |
| October 15, 2024 | 0.6014 |
| October 14, 2024 | 0.5976 |
| October 11, 2024 | 0.5937 |
| October 10, 2024 | 0.5552 |
| October 09, 2024 | 0.6246 |
| October 08, 2024 | 0.6361 |
| October 07, 2024 | 0.613 |
| October 04, 2024 | 0.6477 |
| October 03, 2024 | 0.6631 |
| October 02, 2024 | 0.7055 |
| October 01, 2024 | 0.7171 |
| September 30, 2024 | 0.7017 |
| September 27, 2024 | 0.6513 |
| September 26, 2024 | 0.6182 |
| September 25, 2024 | 0.5984 |
| September 24, 2024 | 0.6447 |
| September 23, 2024 | 0.6579 |
| September 20, 2024 | 0.6844 |
| September 19, 2024 | 0.7174 |
| September 18, 2024 | 0.7075 |
| September 17, 2024 | 0.7207 |
| September 16, 2024 | 0.7207 |
| September 13, 2024 | 0.734 |
| September 12, 2024 | 0.7075 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4665
Minimum
Nov 20 2024
16.53
Maximum
Dec 10 2020
3.293
Average
2.077
Median
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.233 |
| Neurocrine Biosciences Inc | 4.656 |
| Eton Pharmaceuticals Inc | 17.33 |
| Verve Therapeutics Inc | 0.7650 |
| Immuneering Corp | 1.135 |
Price to Book Value Related Metrics
| PS Ratio | 17.99 |
| Price | 1.29 |
| Earnings Yield | -230.2% |
| Market Cap | 68.04M |